{"id":2064,"date":"2010-12-13T00:00:00","date_gmt":"2010-12-13T08:00:00","guid":{"rendered":"https:\/\/vermont.salk.edu\/news-release\/the-stemness-of-cancer-cells\/"},"modified":"2010-12-13T00:00:00","modified_gmt":"2010-12-13T08:00:00","slug":"the-stemness-of-cancer-cells","status":"publish","type":"disclosure","link":"https:\/\/www.salk.edu\/es\/news-release\/the-stemness-of-cancer-cells\/","title":{"rendered":"The stemness of cancer cells"},"content":{"rendered":"<p>LA JOLLA, CA\u2014A close collaboration between researchers at the Salk Institute for Biological Studies and the Institute for Advanced Study found that the tumor suppressor p53, long thought of as the &#8220;Guardian of the Genome,&#8221; may do more than thwart cancer-causing mutations. It may also prevent established cancer cells from sliding toward a more aggressive, stem-like state by serving as a &#8220;Guardian against Genome Reprogramming.&#8221;\n<\/p>\n<p>\nThe new work, reported by <a href=\"\/es\/faculty\/wahl.html\/\">Geoffrey M. Wahl<\/a>, Ph.D., and Benjamin Spike, Ph.D., at Salk Institute and Arnold J. Levine, Ph.D., and Hideaki Mizuno, Ph.D., at IAS, Princeton, in this week&#8217;s online edition of the <em>Actas de la Academia Nacional de Ciencias<\/em>, revealed striking parallels between the increased reprogramming efficiency of normal adult cells lacking p53, the inherent plasticity and tumorigenicity of stem cells, and the high incidence of p53 mutations in malignant cancers.\n<\/p>\n<p>\n&#8220;A poorly differentiated appearance, cellular and genetic heterogeneity are well- known hallmarks of many aggressive and deadly cancers,&#8221; explains Wahl, a professor in the Gene Expression Laboratory at Salk, &#8220;and it has recently been suggested that these properties result from the presence of stem-like cancer cells. Our findings indicate that p53 mutations could allow cells within a tumor to turn back time by acquiring a stem cell\u2013like &#8216;program.'&#8221;\n<\/p>\n<div class=\"imageCaption500\"><img decoding=\"async\" src=\"https:\/\/www.salk.edu\/wp-content\/uploads\/2015\/03\/455_wahl.jpg\" alt=\"Model of reprogramming in Tumors\"><\/p>\n<p>The tumor suppressor p53 prevents established cancer cells from sliding toward a more aggressive, stem-like state.<\/p>\n<p>Illustration: Courtesy of Dr. Benjamin Spike, Salk Institute for Biological Studies.<\/p>\n<\/div>\n<p>\nCancer cells need to acquire some of the characteristics of stem cells to survive and adapt to ever-changing environments. These include immortality, the ability to self-renew and the capacity to produce progenitors that differentiate into other cell types. &#8220;Each tumor represents a diverse collection of cancer cells,&#8221; says Wahl, &#8220;and the question was how best to explain how such heterogeneity arises.&#8221;\n<\/p>\n<p>\nIn the past, the cellular diversity of cancers has mostly been attributed to genetic instability, which many years ago Wahl and his team showed to occur when p53 is disabled. As the tumor cell population expands, so goes the prevailing theory, individual cells pick up random mutations, and their molecular identity starts to diverge. By the time the cancer is detected, the millions of cells that make up the tumor have become as different from each other as third cousins twice removed.\n<\/p>\n<p>\nThere had also been a longstanding notion that fully committed and specialized cells might de-differentiate over the course of tumor initiation and progression, although it was unclear how this might be achieved. Eventually the theory was discarded in favor of the currently fashionable cancer stem cell theory, which holds that cancer stem cells\u2014the cells that propagate a tumor and that could potentially arise from normal stem or early progenitors\u2014are distinct from the bulk of the cancer cells in that they can self-renew as well as produce non-stem cells, just as normal stem cells do.\n<\/p>\n<p>\n&#8220;Our findings indicate that cancer cells that resemble stem cells need not be part of the original tumor but rather may emerge during later stages of tumor development, facilitated by the loss of p53,&#8221; says postdoctoral researcher and co-first author Benjamin T. Spike, Ph.D. &#8220;The observed tumor heterogeneity is probably a combination of growing genomic instability <em>y<\/em> epigenetic instability associated with the acquisition of a stem cell\u2013like phenotype.&#8221;\n<\/p>\n<p>\nWahl and his team first considered the possibility that p53 does more then function as a &#8220;genome guardian&#8221; when a collaborative study with Juan-Carlos Izpis\u00faa Belmonte, Ph.D., also a professor in the Gene Expression Laboratory at the Salk Institute, revealed that this tumor suppressor also presents a barrier to somatic cell reprogramming.\n<\/p>\n<p>\nTo find out whether p53 inactivation does permit the emergence of tumor cells resembling stem cells, Spike and Mizuno combed through hundreds of archival gene expression profiles of breast and lung tumors, searching for stem cell\u2013like signatures and correlating them to their p53 status.\n<\/p>\n<p>\n&#8220;We found a close correlation between tumors with confirmed p53 mutations or overt p53 inactivation and gene expression patterns typical of stem cells,&#8221; Spike explains. &#8220;It will influence the way we think about p53 since its loss now seems to have reverberations beyond removing the immediate cell death and proliferation barriers to tumorigenicity.&#8221;\n<\/p>\n<p>\nWahl hopes that gaining a better understanding of the process that allows tumor cells to revert to a more stem-like state will reveal new targets for therapeutic intervention. &#8220;More stem-like tumors appear to be more aggressive, but they still may have residual capacity to differentiate into less aggressive cell types,&#8221; he says. &#8220;If we can tap into this potential, we may be able to force these cells to differentiate to become less dangerous, which is an old idea that we need to seriously reconsider.&#8221;\n<\/p>\n<p>\nThe closeness of the collaboration is indicated by the sharing of the first authorship between Spike and Mizuno, who is now at Chugai Pharmaceutical Co. Ltd., in Kamakura, Japan.\n<\/p>\n<p>\nThe work at Salk was funded by the Breast Cancer Research Foundation, the G. Harold and Leila Y. Mathers Charitable Foundation, the National Cancer Institute and a Ruth L. Kirschstein National Research Service Award. <\/p>\n<p><strong><br \/>\nAcerca del Instituto Salk de Estudios Biol\u00f3gicos<\/strong><br \/>\nEl Instituto Salk de Estudios Biol\u00f3gicos es una de las instituciones de investigaci\u00f3n b\u00e1sica m\u00e1s destacadas del mundo, donde un cuerpo docente de prestigio internacional investiga cuestiones fundamentales de las ciencias de la vida en un entorno \u00fanico, colaborativo y creativo. Centrados tanto en el descubrimiento como en la formaci\u00f3n de las futuras generaciones de investigadores, los cient\u00edficos del Salk realizan contribuciones revolucionarias a nuestra comprensi\u00f3n del c\u00e1ncer, el envejecimiento, el Alzheimer, la diabetes y las enfermedades infecciosas mediante el estudio de la neurociencia, la gen\u00e9tica, la biolog\u00eda celular y vegetal, y otras disciplinas relacionadas.<\/p>\n<p>\nLos logros del cuerpo docente han sido reconocidos con numerosos galardones, entre los que se incluyen premios Nobel y la pertenencia a la Academia Nacional de Ciencias. Fundado en 1960 por el Dr. Jonas Salk, pionero en la vacuna contra la poliomielitis, el Instituto es una organizaci\u00f3n independiente sin fines de lucro y un hito arquitect\u00f3nico.\n<\/p>\n<p>El Instituto Salk se enorgullece de celebrar cinco d\u00e9cadas de excelencia cient\u00edfica en la investigaci\u00f3n b\u00e1sica.<\/p>","protected":false},"featured_media":0,"template":"","faculty":[90],"disease-research":[],"class_list":["post-2064","disclosure","type-disclosure","status-publish","hentry","faculty-geoffrey-wahl"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The stemness of cancer cells - Salk Institute for Biological Studies<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.salk.edu\/es\/news-release\/the-stemness-of-cancer-cells\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The stemness of cancer cells - Salk Institute for Biological Studies\" \/>\n<meta property=\"og:description\" content=\"LA JOLLA, CA\u2014A close collaboration between researchers at the Salk Institute for Biological Studies and the Institute for Advanced Study found that the tumor suppressor p53, long thought of as the &#8220;Guardian of the Genome,&#8221; may do more than thwart cancer-causing mutations. It may also prevent established cancer cells from sliding toward a more aggressive, stem-like state by serving as a &#8220;Guardian against Genome Reprogramming.&#8221;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.salk.edu\/es\/news-release\/the-stemness-of-cancer-cells\/\" \/>\n<meta property=\"og:site_name\" content=\"Salk Institute for Biological Studies\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.salk.edu\/wp-content\/uploads\/2023\/03\/salk-institute-preview-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"628\" \/>\n\t<meta property=\"og:image:height\" content=\"329\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/the-stemness-of-cancer-cells\\\/\",\"url\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/the-stemness-of-cancer-cells\\\/\",\"name\":\"The stemness of cancer cells - Salk Institute for Biological Studies\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/the-stemness-of-cancer-cells\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/the-stemness-of-cancer-cells\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2015\\\/03\\\/455_wahl.jpg\",\"datePublished\":\"2010-12-13T08:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/the-stemness-of-cancer-cells\\\/#breadcrumb\"},\"inLanguage\":\"es-MX\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/the-stemness-of-cancer-cells\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es-MX\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/the-stemness-of-cancer-cells\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2015\\\/03\\\/455_wahl.jpg\",\"contentUrl\":\"https:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2015\\\/03\\\/455_wahl.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/the-stemness-of-cancer-cells\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.salk.edu\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The stemness of cancer cells\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#website\",\"url\":\"https:\\\/\\\/www.salk.edu\\\/\",\"name\":\"Salk Institute for Biological Studies\",\"description\":\"The Power of Science\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.salk.edu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es-MX\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#organization\",\"name\":\"Salk Institute for Biological Studies\",\"url\":\"https:\\\/\\\/www.salk.edu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-MX\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"http:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/salk_logo_696.jpg\",\"contentUrl\":\"http:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/salk_logo_696.jpg\",\"width\":696,\"height\":696,\"caption\":\"Salk Institute for Biological Studies\"},\"image\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The stemness of cancer cells - Salk Institute for Biological Studies","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.salk.edu\/es\/news-release\/the-stemness-of-cancer-cells\/","og_locale":"es_MX","og_type":"article","og_title":"The stemness of cancer cells - Salk Institute for Biological Studies","og_description":"LA JOLLA, CA\u2014A close collaboration between researchers at the Salk Institute for Biological Studies and the Institute for Advanced Study found that the tumor suppressor p53, long thought of as the &#8220;Guardian of the Genome,&#8221; may do more than thwart cancer-causing mutations. It may also prevent established cancer cells from sliding toward a more aggressive, stem-like state by serving as a &#8220;Guardian against Genome Reprogramming.&#8221;","og_url":"https:\/\/www.salk.edu\/es\/news-release\/the-stemness-of-cancer-cells\/","og_site_name":"Salk Institute for Biological Studies","og_image":[{"width":628,"height":329,"url":"https:\/\/www.salk.edu\/wp-content\/uploads\/2023\/03\/salk-institute-preview-image.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.salk.edu\/news-release\/the-stemness-of-cancer-cells\/","url":"https:\/\/www.salk.edu\/news-release\/the-stemness-of-cancer-cells\/","name":"The stemness of cancer cells - Salk Institute for Biological Studies","isPartOf":{"@id":"https:\/\/www.salk.edu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.salk.edu\/news-release\/the-stemness-of-cancer-cells\/#primaryimage"},"image":{"@id":"https:\/\/www.salk.edu\/news-release\/the-stemness-of-cancer-cells\/#primaryimage"},"thumbnailUrl":"https:\/\/www.salk.edu\/wp-content\/uploads\/2015\/03\/455_wahl.jpg","datePublished":"2010-12-13T08:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.salk.edu\/news-release\/the-stemness-of-cancer-cells\/#breadcrumb"},"inLanguage":"es-MX","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.salk.edu\/news-release\/the-stemness-of-cancer-cells\/"]}]},{"@type":"ImageObject","inLanguage":"es-MX","@id":"https:\/\/www.salk.edu\/news-release\/the-stemness-of-cancer-cells\/#primaryimage","url":"https:\/\/www.salk.edu\/wp-content\/uploads\/2015\/03\/455_wahl.jpg","contentUrl":"https:\/\/www.salk.edu\/wp-content\/uploads\/2015\/03\/455_wahl.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.salk.edu\/news-release\/the-stemness-of-cancer-cells\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.salk.edu\/"},{"@type":"ListItem","position":2,"name":"The stemness of cancer cells"}]},{"@type":"WebSite","@id":"https:\/\/www.salk.edu\/#website","url":"https:\/\/www.salk.edu\/","name":"Instituto Salk de Estudios Biol\u00f3gicos","description":"The Power of Science","publisher":{"@id":"https:\/\/www.salk.edu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.salk.edu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es-MX"},{"@type":"Organization","@id":"https:\/\/www.salk.edu\/#organization","name":"Instituto Salk de Estudios Biol\u00f3gicos","url":"https:\/\/www.salk.edu\/","logo":{"@type":"ImageObject","inLanguage":"es-MX","@id":"https:\/\/www.salk.edu\/#\/schema\/logo\/image\/","url":"http:\/\/www.salk.edu\/wp-content\/uploads\/2023\/03\/salk_logo_696.jpg","contentUrl":"http:\/\/www.salk.edu\/wp-content\/uploads\/2023\/03\/salk_logo_696.jpg","width":696,"height":696,"caption":"Salk Institute for Biological Studies"},"image":{"@id":"https:\/\/www.salk.edu\/#\/schema\/logo\/image\/"}}]}},"ACF":{"paper_url":"","journal_title":"","paper_author_list":"","paper_title":"","subhead":"","home_photo":"455_WahlSpikeHeadshot.jpg","listing_photo":"","line_2":"","line_1":"The stemness of cancer cells"},"_links":{"self":[{"href":"https:\/\/www.salk.edu\/es\/wp-json\/wp\/v2\/disclosure\/2064","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.salk.edu\/es\/wp-json\/wp\/v2\/disclosure"}],"about":[{"href":"https:\/\/www.salk.edu\/es\/wp-json\/wp\/v2\/types\/disclosure"}],"version-history":[{"count":0,"href":"https:\/\/www.salk.edu\/es\/wp-json\/wp\/v2\/disclosure\/2064\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.salk.edu\/es\/wp-json\/wp\/v2\/media?parent=2064"}],"wp:term":[{"taxonomy":"faculty","embeddable":true,"href":"https:\/\/www.salk.edu\/es\/wp-json\/wp\/v2\/faculty?post=2064"},{"taxonomy":"disease-research","embeddable":true,"href":"https:\/\/www.salk.edu\/es\/wp-json\/wp\/v2\/disease-research?post=2064"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}